The Standing Record

A daily, non-partisan record of US democratic norms — and the events that erode them.

FTC sues WPATH, the leading transgender medical standards body, alleging 'deceptive claims' on youth care

The Federal Trade Commission filed suit on June 17, 2026, against the World Professional Association for Transgender Health (WPATH), alleging the organization made "deceptive claims" about gender-affirming care for minors and that its members profited from those claims. Four state attorneys general — Alaska, Iowa, Nebraska, and Texas — joined the suit. The action came after a federal judge ruled in May 2026 that an earlier FTC investigation of WPATH likely violated the organization's First Amendment rights, and as the FTC conducted parallel investigations into two other major medical bodies — the American Academy of Pediatrics and the Endocrine Society — over their gender-affirming care guidelines.

Jurisdiction
federal
Location
Washington, D.C.

Abuses documented

Actors

  • Andrew Ferguson (FTC Chair)
  • Federal Trade Commission
  • Attorney General of Alaska
  • Attorney General of Iowa
  • Attorney General of Nebraska
  • Attorney General of Texas

On June 17, 2026, the Federal Trade Commission filed a lawsuit against the World Professional Association for Transgender Health (WPATH), the international medical organization that has set evidence-based standards for transgender care for more than five decades. FTC Chair Andrew Ferguson announced the suit, which alleges WPATH made "deceptive claims" about gender-affirming care for minors and that its members financially benefited from those claims. The attorneys general of Alaska, Iowa, Nebraska, and Texas filed parallel state-level actions joining the federal suit.

The lawsuit came despite a significant legal setback for the agency: in May 2026, a federal judge ruled that an earlier FTC investigation of WPATH was likely violating the organization's First Amendment rights and temporarily blocked it. WPATH characterized the lawsuit as "pure retaliation" and part of what it described as a "relentless and targeted campaign to undermine gender-affirming care by attacking the First Amendment rights and the independence of professional medical organizations." The FTC has launched parallel investigations into the American Academy of Pediatrics and the Endocrine Society — the two other principal U.S. medical bodies that publish guidelines endorsing gender-affirming care for minors — and both organizations have filed suit to block those probes.

The Standing records this event because it is part of a documented pattern in which the administration has used federal regulatory power — consumer-protection law, in this instance — to suppress the professional speech of medical organizations that publish standards supporting care for transgender people. Deploying FTC enforcement authority against a standards-setting body on the basis of its published clinical guidelines, after a court found probable First Amendment violations in the preceding investigation and while simultaneously targeting two other major medical associations for the same kind of speech, reflects the systematic application of government power against a specific marginalized group and the institutions that serve them.

Why we recorded this

Federal agencies have a long-established duty to promote and enforce civil rights, not wield regulatory power against medical organizations for adhering to evidence-based standards. When the FTC files suit against WPATH — the field's leading standards body — for publishing clinical guidelines, it signals that standard-setting in transgender healthcare has become a federal enforcement target. The action is part of a documented pattern: the FTC launched parallel investigations of the American Academy of Pediatrics and the Endocrine Society for their gender-affirming care guidelines, and a federal court had already found in May 2026 that an earlier FTC investigation of WPATH was likely violating the organization's First Amendment rights. Using consumer-protection law against professional medical speech to suppress care for a marginalized group is a form of government targeting through discriminatory application of regulatory power.

Sources

  1. Federal Trade Commission sues leading transgender health group — The Guardian primary accessed June 18, 2026
  2. F.T.C. Sues Group That Advises on Transgender Medical Treatments — New York Times primary accessed June 18, 2026
  3. Republican states join Trump FTC in lawsuit against world's leading transgender health care group — The Advocate secondary accessed June 18, 2026

See also